A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Washington University School of Medicine
Columbia University
St. Joseph's Hospital and Medical Center, Phoenix
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Sheffield Teaching Hospitals NHS Foundation Trust
Corcept Therapeutics
Corcept Therapeutics
Corcept Therapeutics